摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

L-2-(4-溴苯基)-1,3-噻唑烷-4-羧酸 | 294866-41-4

中文名称
L-2-(4-溴苯基)-1,3-噻唑烷-4-羧酸
中文别名
——
英文名称
(2RS,4R)-2-(4-bromophenyl)-1,3-thiazolidine-4-carboxylic acid
英文别名
(2RS,4R)-2-(4-bromophenyl)-thiazolidine-4-carboxylic acid;(4R)-2-(4-bromophenyl)thiazolidine-4-carboxylic acid;(4R)-2-(4-bromophenyl)-1,3-thiazolidine-4-carboxylic acid
L-2-(4-溴苯基)-1,3-噻唑烷-4-羧酸化学式
CAS
294866-41-4
化学式
C10H10BrNO2S
mdl
——
分子量
288.165
InChiKey
TYLJHTCYCWHWRG-IENPIDJESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    474.0±45.0 °C(Predicted)
  • 密度:
    1.629±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    74.6
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2934999090

SDS

SDS:9a6a0dc06da3481dec36d4fb721c0c22
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    乙酸酐L-2-(4-溴苯基)-1,3-噻唑烷-4-羧酸吡啶 为溶剂, 反应 8.0h, 以82%的产率得到(2S,4R)-3-acetyl-2-(4-bromophenyl)-1,3-thiazolidine-4-carboxylic acid
    参考文献:
    名称:
    Gyoergydeak, Zoltan; Kajtar-Peredy, Maria; Kajtar, Judit, Liebigs Annalen der Chemie, 1987, p. 927 - 934
    摘要:
    DOI:
  • 作为产物:
    描述:
    L-半胱氨酸对溴苯甲醛乙醇 为溶剂, 反应 6.0h, 以87%的产率得到L-2-(4-溴苯基)-1,3-噻唑烷-4-羧酸
    参考文献:
    名称:
    半胱氨酸及其衍生物作为新型抗病毒和抗真菌药物的发现
    摘要:
    基于天然产物半胱氨酸的结构,设计合成了一系列噻唑烷-4-羧酸。所有带有噻唑烷-4-甲酸的目标化合物均通过 1H-NMR、13C-NMR 和 HRMS 技术进行了表征。在体外和体内评估了半胱氨酸及其衍生物的抗病毒和抗真菌活性。抗TMV活性结果表明,所有化合物在浓度为500 μg/mL时均表现出中等至优异的抗烟草花叶病毒(TMV)活性。化合物半胱氨酸 (1)、3-4、7、10、13、20、23 和 24 比商业植物杀病毒剂利巴韦林表现出更高的抗 TMV 活性(抑制率:40%、40% 和 38%,500 μg/ mL,分别用于体内灭活、治疗和保护活性),特别是化合物 3(500 μg/mL 时,体内灭活、治疗和保护活性的抑制率分别为 51%、47% 和 49%)优异的抗病毒活性成为新的抗病毒候选药物。TEM抗病毒机制研究表明,化合物3可以通过聚集20S蛋白盘来抑制病毒组装。分子对接结果显示,抗病
    DOI:
    10.3390/molecules26020383
点击查看最新优质反应信息

文献信息

  • Synthesis, characterization and antibacterial activities of N-tert-butoxycarbonyl-thiazolidine carboxylic acid
    作者:Zhong-Cheng Song、Gao-Yuan Ma、Hai-Liang Zhu
    DOI:10.1039/c4ra15284k
    日期:——

    The mechanism of dynamic kinetic resolution, a nucleophilic substitution through an intramolecular hydrogen bonding by the formation of N-Boc-TCAs was proposed and a qualitative explanation was interpretated according to Curtin–Hammett principle.

    动力学选择性分辨机制是通过形成N-Boc-TCAs的分子内氢键进行亲核取代,根据Curtin-Hammett原理提出了定性解释。
  • One-pot double annulations to confer diastereoselective spirooxindolepyrrolothiazoles
    作者:Juan Lu、Bin Yao、Desheng Zhan、Zhuo Sun、Yun Ji、Xiaofeng Zhang
    DOI:10.3762/bjoc.18.171
    日期:——
    four-component reaction in one pot as an atom- and step-economic process was developed to synthesize diastereoselectively spirooxindolepyrrolothiazoles through sequential N,S-acetalation of aldehydes with cysteine and decarboxylative [3 + 2] cycloaddition with olefinic oxindoles. High synthetic efficiency, operational simplification and reaction process economy using EtOH as solvent, and only releasing
    开发了一种新型四组分一锅反应,作为一种原子分步经济工艺,通过醛与半胱氨酸的连续N,S-缩醛化和与烯属羟吲哚的脱羧 [3 + 2] 环加成来合成非对映选择性螺环吲哚吡咯并噻唑。使用EtOH作为溶剂且仅释放CO 2和H 2 O作为副产物的高合成效率、操作简化和反应过程经济性使得该方法有利于绿色化学指标分析。
  • Acharya, Jiba Raj; Zhang, Huating; Li, Xian, Journal of the American Chemical Society, 2009, vol. 131, p. 880 - 881
    作者:Acharya, Jiba Raj、Zhang, Huating、Li, Xian、Nesterov, Evgueni E.
    DOI:——
    日期:——
  • Discovery of 2-Arylthiazolidine-4-carboxylic Acid Amides as a New Class of Cytotoxic Agents for Prostate Cancer
    作者:Veeresa Gududuru、Eunju Hurh、James T. Dalton、Duane D. Miller
    DOI:10.1021/jm049208b
    日期:2005.4.1
    To improve the selectivity and antiproliferative activity of previously reported serine amide phosphates (SAPs), we designed a new series of 4-thiazolidinone amides, in which the 4-thiazolidinone moiety was introduced as a phosphate mimic. However, these 4-thiazolidinone derivatives demonstrated less cytotoxicity in prostate cancer cells despite improved selectivity over RH7777 cells. To further optimize the thiazolidinone analogues in terms of cytotoxicity and selectivity, we made closely related structural modifications, which led us to the discovery of a new class of 2-arylthiazolidine-4-carboxylic acid amides. These compounds were potent cytotoxic agents with IC50 values in the low micromolar concentration range and demonstrated enhanced selectivity in receptor-negative cells compared to SAPs and 4-thiazolidinone amides.
  • Synthesis, structure and structure–activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents
    作者:Zhong-Cheng Song、Gao-Yuan Ma、Peng-Cheng Lv、Huan-Qiu Li、Zhu-Ping Xiao、Hai-Liang Zhu
    DOI:10.1016/j.ejmech.2009.04.014
    日期:2009.10
    Nine 2-arylthiazolidine-4-carboxylic acid derivatives and nine 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives were synthesized to screen for their antibacterial activities. Compounds S, 14-18 were first reported. Their chemical structures were clearly determined by H-1 NMR, C-13 NMR, ESI mass spectra and elemental analyses, coupled with one selected single-crystal structure. All the compounds were assayed for antibacterial activities against two Gram-positive bacterial strains (Bacillus subtilis ATCC 6633 and Staphylococcus aureus ATCC 6538) and two Gram-negative bacterial strains (Escherichia coli ATCC 35218 and Pseudomonas aeruginosa ATCC 13525) by MTT method. Most of the 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives exhibited better antibacterial activities against the four bacterial strains than relative 2-arylthiazolidine-4-carboxylic acid derivatives. Compound (2RS,4R)-3-(tert-butoxycarbonyl)-2-(5-fluoro-2-hydroxyphenyl)thiazolidine-4-carboxylic acid (14) showed powerful antibacterial activities against P aeruginosa with IC50 value of 0.195 mu g/mL, which was superior to the positive controls Penicillin G and Kanamycin B, respectively. On the basis of the biological results, structure-activity relationships were discussed. (C) 2009 Elsevier Masson SAS. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物